Cargando...
SUN-155 Clinical Experience of SGLT2 Inhibitors in a Hispanic Population: Should We Consider Its Use as Add-On Treatment?
Introduction: 1 in 11 adults have DM globally,(1) and Hispanics have higher complication rates.(2) A study determined that ~$16,750/year are spent by patients in medical related costs, of which ~$9,600 are related to diabetes.(3) Half of Type 2 Diabetes Mellitus (T2DM) patients aren't achieving...
Guardado en:
| Publicado en: | J Endocr Soc |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Endocrine Society
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553393/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-155 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|